Dan German BlazerIII
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dan German BlazerIII has a total of 418 co-authors. Here are the top co-authors by number of shared publications:
Douglas S. Tyler
Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA
15 shared publications- Daniel P. Nussbaum
Department of Surgery, Duke University School of Medicine, Durham, NC
13 shared publications Bryan M. Clary
Department of Surgery, Duke University, Durham, North California
12 shared publicationsDaniel P. Nussbaum
Department of Surgery, Duke University School of Medicine, Durham, USA
12 shared publicationsPaul J. Speicher
10 shared publicationsSabino Zani
Department of Surgery (Zani, Blazer), Duke University Medical Center, Durham, NC
8 shared publications
Latest Publications
- 14 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Hepatopancreatobiliary (HPB) malignancies are associated with high morbidity and frequent invasive procedures near the end of life. Although palliative care improves quality of life and goal-concordant care, its relationship with procedural burden in HPB cancers at the end of life remains poorly understood. We evaluated associations between inpatient palliative care and end-of-life procedural intensity in HPB malignancies. We conducted a retrospective analysis of adult patients with HPB cancers admitted to a tertiary academic health system within 6 months of death between January 1, 2013, and December 31, 2024. Electronic health records and tumor registry data were analyzed through June 1, 2025. Patients were categorized by inpatient procedures and palliative care consultations. The primary outcome was the relationship between palliative care involvement and inpatient procedural burden. Multivariable logistic regression evaluated associations between palliative care timing and procedural characteristics. Among 2,848 patients, 1,373 (48.2%) underwent an inpatient procedure and 1,160 (40.7%) received palliative care consultation. From 2013 to 2024, palliative care utilization more than doubled, while end-of-life procedural rates remained constant. Palliative care involvement prior to any procedure was associated with lower odds of undergoing nonpalliative-intent procedures relative to palliative-intent procedures (odds ratio [OR] 0.71, 95% confidence interval [CI] 0.51-0.98; P = 0.038). End-of-life inpatient procedures were common in HPB malignancies and persisted despite increased palliative care utilization. Early palliative care involvement was associated with a greater proportion of palliative-type procedures, suggesting an association between earlier palliative care integration and procedural decision-making that may better align with patient quality of life and end-of-life priorities.
- 14 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Hepatopancreatobiliary (HPB) malignancies are associated with high morbidity and frequent invasive procedures near the end of life. Although palliative care improves quality of life and goal-concordant care, its relationship with procedural burden in HPB cancers at the end of life remains poorly understood. We evaluated associations between inpatient palliative care and end-of-life procedural intensity in HPB malignancies. We conducted a retrospective analysis of adult patients with HPB cancers admitted to a tertiary academic health system within 6 months of death between January 1, 2013, and December 31, 2024. Electronic health records and tumor registry data were analyzed through June 1, 2025. Patients were categorized by inpatient procedures and palliative care consultations. The primary outcome was the relationship between palliative care involvement and inpatient procedural burden. Multivariable logistic regression evaluated associations between palliative care timing and procedural characteristics. Among 2,848 patients, 1,373 (48.2%) underwent an inpatient procedure and 1,160 (40.7%) received palliative care consultation. From 2013 to 2024, palliative care utilization more than doubled, while end-of-life procedural rates remained constant. Palliative care involvement prior to any procedure was associated with lower odds of undergoing nonpalliative-intent procedures relative to palliative-intent procedures (odds ratio [OR] 0.71, 95% confidence interval [CI] 0.51-0.98; P = 0.038). End-of-life inpatient procedures were common in HPB malignancies and persisted despite increased palliative care utilization. Early palliative care involvement was associated with a greater proportion of palliative-type procedures, suggesting an association between earlier palliative care integration and procedural decision-making that may better align with patient quality of life and end-of-life priorities.
- 13 August 2023
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 31 (12) , 1114-1116
Resilience and the COVID Pandemic
- 13 August 2023
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 31 (12) , 1114-1116
Resilience and the COVID Pandemic
- 10 January 2023
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 236 (4) , 698-708
Closed Incision Negative Pressure Therapy to Reduce Surgical Site Infection in High-Risk Gastrointestinal Surgery: A Randomized Controlled Trial
BACKGROUND: Despite institutional perioperative bundles and national infection prevention guidelines, surgical site infection (SSI) after a major abdominal operation remains a significant source of morbidity. Negative pressure therapy (NPT) has revolutionized care for open wounds but the role of closed incision NPT (ciNPT) remains unclear. STUDY DESIGN: We conducted a multi-institutional randomized controlled trial evaluating SSI after major elective colorectal or hepatopancreatobiliary surgery (Clinical Trial Registration: NCT01905397). Patients were randomized to receive conventional wound care vs ciNPT (Prevena Incision Management System, 3M Health Care, San Antonio, TX). The primary endpoint was postoperative incisional SSI. SSI incidence was evaluated at inpatient days 4 or 5 and again at postoperative day 30. With 144 patients studied, the estimated power was 85% for detecting a difference in SSIs between 17% and 5% (conventional vs ciNPT; 1-sided α = 0.1). Secondary endpoints included SSI type, length of stay, 30-day readmission, and mortality. T-tests were used to compare continuous variables between treatments; similarly, chi-square tests were used to compare categorical variables. A p value of <0.05 was considered significant, except in the primary comparison of incisional and organ SSIs. RESULTS: During the 2013 to 2021 time period, 164 patients were randomized, and of those, 138 were evaluable (ciNPT n = 63; conventional n = 75). Incisional SSIs occurred in 9 (14%) patients in the ciNPT group and 13 (17%) patients in the conventional group (p = 0.31). Organ or space SSIs occurred in 7 (11%) patients in the ciNPT group and 10 (13%) in the conventional therapy group (p = 0.35). CONCLUSIONS: In this multi-institutional, randomized controlled trial of patients undergoing colorectal or hepatopancreatobiliary surgery, incidence of incisional SSIs between ciNPT and conventional wound therapy was not statistically significant. Future trials should focus on patient populations undergoing specific procedures types that have the highest risk for SSI.
- 10 January 2023
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 236 (4) , 698-708
Closed Incision Negative Pressure Therapy to Reduce Surgical Site Infection in High-Risk Gastrointestinal Surgery: A Randomized Controlled Trial
BACKGROUND: Despite institutional perioperative bundles and national infection prevention guidelines, surgical site infection (SSI) after a major abdominal operation remains a significant source of morbidity. Negative pressure therapy (NPT) has revolutionized care for open wounds but the role of closed incision NPT (ciNPT) remains unclear. STUDY DESIGN: We conducted a multi-institutional randomized controlled trial evaluating SSI after major elective colorectal or hepatopancreatobiliary surgery (Clinical Trial Registration: NCT01905397). Patients were randomized to receive conventional wound care vs ciNPT (Prevena Incision Management System, 3M Health Care, San Antonio, TX). The primary endpoint was postoperative incisional SSI. SSI incidence was evaluated at inpatient days 4 or 5 and again at postoperative day 30. With 144 patients studied, the estimated power was 85% for detecting a difference in SSIs between 17% and 5% (conventional vs ciNPT; 1-sided α = 0.1). Secondary endpoints included SSI type, length of stay, 30-day readmission, and mortality. T-tests were used to compare continuous variables between treatments; similarly, chi-square tests were used to compare categorical variables. A p value of <0.05 was considered significant, except in the primary comparison of incisional and organ SSIs. RESULTS: During the 2013 to 2021 time period, 164 patients were randomized, and of those, 138 were evaluable (ciNPT n = 63; conventional n = 75). Incisional SSIs occurred in 9 (14%) patients in the ciNPT group and 13 (17%) patients in the conventional group (p = 0.31). Organ or space SSIs occurred in 7 (11%) patients in the ciNPT group and 10 (13%) in the conventional therapy group (p = 0.35). CONCLUSIONS: In this multi-institutional, randomized controlled trial of patients undergoing colorectal or hepatopancreatobiliary surgery, incidence of incisional SSIs between ciNPT and conventional wound therapy was not statistically significant. Future trials should focus on patient populations undergoing specific procedures types that have the highest risk for SSI.
- 9 October 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (1) , 211-219
CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma
Purpose Treatment for gastroesophageal adenocarcinomas can result in significant morbidity and mortality. The purpose of this study is to supplement methods for choosing treatment strategy by assessing the relationship between CT-derived body composition, patient, and tumor features, and clinical outcomes in this population. Methods Patients with neoadjuvant treatment, biopsy-proven gastroesophageal adenocarcinoma, and initial staging CTs were retrospectively identified from institutional clinic encounters between 2000 and 2019. Details about patient, disease, treatment, and outcomes (including therapy tolerance and survival) were extracted from electronic medical records. A deep learning semantic segmentation algorithm was utilized to measure cross-sectional areas of skeletal muscle (SM), visceral fat (VF), and subcutaneous fat (SF) at the L3 vertebra level on staging CTs. Univariate and multivariate analyses were performed to assess the relationships between predictors and outcomes. Results 142 patients were evaluated. Median survival was 52 months. Univariate and multivariate analysis showed significant associations between treatment tolerance and SM and VF area, SM to fat and VF to SF ratios, and skeletal muscle index (SMI) (p = 0.004–0.04). Increased survival was associated with increased body mass index (BMI) (p = 0.01) and increased SMI (p = 0.004). A multivariate Cox model consisting of BMI, SMI, age, gender, and stage demonstrated that patients in the high-risk group had significantly lower survival (HR = 1.77, 95% CI = 1.13–2.78, p = 0.008). Conclusion CT-based measures of body composition in patients with gastroesophageal adenocarcinoma may be independent predictors of treatment complications and survival and can supplement methods for assessing functional status during treatment planning. Graphical abstract
- 9 October 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (1) , 211-219
CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma
Purpose Treatment for gastroesophageal adenocarcinomas can result in significant morbidity and mortality. The purpose of this study is to supplement methods for choosing treatment strategy by assessing the relationship between CT-derived body composition, patient, and tumor features, and clinical outcomes in this population. Methods Patients with neoadjuvant treatment, biopsy-proven gastroesophageal adenocarcinoma, and initial staging CTs were retrospectively identified from institutional clinic encounters between 2000 and 2019. Details about patient, disease, treatment, and outcomes (including therapy tolerance and survival) were extracted from electronic medical records. A deep learning semantic segmentation algorithm was utilized to measure cross-sectional areas of skeletal muscle (SM), visceral fat (VF), and subcutaneous fat (SF) at the L3 vertebra level on staging CTs. Univariate and multivariate analyses were performed to assess the relationships between predictors and outcomes. Results 142 patients were evaluated. Median survival was 52 months. Univariate and multivariate analysis showed significant associations between treatment tolerance and SM and VF area, SM to fat and VF to SF ratios, and skeletal muscle index (SMI) (p = 0.004–0.04). Increased survival was associated with increased body mass index (BMI) (p = 0.01) and increased SMI (p = 0.004). A multivariate Cox model consisting of BMI, SMI, age, gender, and stage demonstrated that patients in the high-risk group had significantly lower survival (HR = 1.77, 95% CI = 1.13–2.78, p = 0.008). Conclusion CT-based measures of body composition in patients with gastroesophageal adenocarcinoma may be independent predictors of treatment complications and survival and can supplement methods for assessing functional status during treatment planning. Graphical abstract
- 14 September 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 7947-7949
Supply and Demand: Is the Surgical Oncology Match in a Bear Market?
- 14 September 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 7947-7949
Supply and Demand: Is the Surgical Oncology Match in a Bear Market?
- Open Access
- 1 June 2022
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (7) , A2-A3
Table of Contents
- 1 June 2022
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (7) , A2-A3
Open AccessTable of Contents
- 19 January 2022
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 234 (4) , 632-644
Quality of Life Associated with Open vs Minimally Invasive Pancreaticoduodenectomy: A Prospective Pilot Study
BACKGROUND: This prospective study was designed to compare quality of life (QoL) among patients who underwent open (O-PD) vs minimally invasive pancreaticoduodenectomy (MI-PD), using a combination of validated qualitative and quantitative methodologies. STUDY DESIGN: From 2017 to 2019, patients scheduled for pancreaticoduodenectomy (PD) were enrolled and presented with Functional Assessment of Cancer Therapy-Hepatobiliary surveys preoperatively, before discharge, at first postoperative visit and approximately 3 to 4 months after operation (“3 months”). Longitudinal plots of median QoL scores were used to illustrate change in each score over time. In a subset of patients, content analysis of semistructured interviews at postoperative time points (1.5 to 6 months after operation) was conducted. RESULTS: Among 56 patients who underwent PD, 33 had an O-PD (58.9%). Physical and functional scores decreased in the postoperative period but returned to baseline by 3 months. No significant differences were found in any domains of QoL at baseline and in the postoperative period between patients who underwent O-PD and MI-PD. Qualitative findings were concordant with quantitative data (n = 14). Patients with O-PD and MI-PD reported similar experiences with complications, pain, and wound healing in the postoperative period. Approximately half the patients in both groups reported “returning to normal” in the 6-month postoperative period. A total of 4 patients reported significant long-term issues with physical and functional well-being. CONCLUSIONS: Using a novel combination of qualitative and quantitative analyses in patients undergoing PD, we found no association between operative approach and QoL in patients who underwent O-PD vs MI-PD. Given the increasing use of minimally invasive techniques for PD and the steep learning curve associated with these techniques, continued assessment of patient benefit is critical. Export
- 19 January 2022
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 234 (4) , 632-644
Quality of Life Associated with Open vs Minimally Invasive Pancreaticoduodenectomy: A Prospective Pilot Study
BACKGROUND: This prospective study was designed to compare quality of life (QoL) among patients who underwent open (O-PD) vs minimally invasive pancreaticoduodenectomy (MI-PD), using a combination of validated qualitative and quantitative methodologies. STUDY DESIGN: From 2017 to 2019, patients scheduled for pancreaticoduodenectomy (PD) were enrolled and presented with Functional Assessment of Cancer Therapy-Hepatobiliary surveys preoperatively, before discharge, at first postoperative visit and approximately 3 to 4 months after operation (“3 months”). Longitudinal plots of median QoL scores were used to illustrate change in each score over time. In a subset of patients, content analysis of semistructured interviews at postoperative time points (1.5 to 6 months after operation) was conducted. RESULTS: Among 56 patients who underwent PD, 33 had an O-PD (58.9%). Physical and functional scores decreased in the postoperative period but returned to baseline by 3 months. No significant differences were found in any domains of QoL at baseline and in the postoperative period between patients who underwent O-PD and MI-PD. Qualitative findings were concordant with quantitative data (n = 14). Patients with O-PD and MI-PD reported similar experiences with complications, pain, and wound healing in the postoperative period. Approximately half the patients in both groups reported “returning to normal” in the 6-month postoperative period. A total of 4 patients reported significant long-term issues with physical and functional well-being. CONCLUSIONS: Using a novel combination of qualitative and quantitative analyses in patients undergoing PD, we found no association between operative approach and QoL in patients who underwent O-PD vs MI-PD. Given the increasing use of minimally invasive techniques for PD and the steep learning curve associated with these techniques, continued assessment of patient benefit is critical. Export